User's Publication |
19503
Cheng A, Kawahata I, Wang Y, Jia W, Wang H, Sekimori T, Chen Y, Suzuki H, Takeda A, Stefanova N, Finkelstein DI, Ma W, Chen M, Sasaki T, Fukunaga K.
Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation
Brain
2023
146(8):3172-3180
PubMed ID: 37082980
DOI: 10.1093/brain/awad137
|
21369
Cheng A, Jia W, Finkelstein DI, Stefanova N, Wang H, Sasaki T, Kawahata I, Fukunaga K.
Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model.
Acta Pharmacol Sin
2023
PubMed ID: 37605049
DOI: 10.1038/s41401-023-01138-y
|
16852
Cheng A, Wang YF, Shinoda Y, Kawahata I, Yamamoto T, Jia WB, Yamamoto H, Mizobata T, Kawata Y, Fukunaga K.
Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress
Acta Pharmacol Sin
2022
43(3):552-562
PubMed ID: 33935286
DOI: 10.1038/s41401-021-00675-8
|
20075
Hisahara S, Iwahara N, Matsushita T, Suzuki S, Matsumura A, Fujikura M, Yokokawa K, Saito T, Manabe T, Kawamata J, Horio Y, Shimohama S.
SIRT1 decelerates morphological processing of oligodendrocyte cell lines and regulates the expression of cytoskeleton-related oligodendrocyte proteins.
Biochem Biophys Res Commun
2021
546:7-14
PubMed ID: 33556638
DOI: 10.1016/j.bbrc.2021.01.095
|
16375
Cheng A, Jia W, Kawahata I, Fukunaga K.
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
EBioMedicine
2021
;72:103582
PubMed ID: 34624687
DOI: 10.1016/j.ebiom.2021.103582
|
13391
Cheng A, Kawahata I, Fukunaga K.
Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes.
Biomedicines
2020
PubMed ID: 33419250
DOI: 10.3390/biomedicines8120635
|
4947
Matsuda Y, Ishiwata T, Yoshimura H, Hagio M, Arai T.
Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71
Cancer Lett
2015
357(2):602-1
PubMed ID: 25527454
DOI: 10.1016/j.canlet.2014.12.030
|
16012
Ohashi R, Matsuda Y, Ishiwata T, Naito Z.
Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma
Oncol Rep
2014
32(3):1163-9
PubMed ID: 24968791
DOI: 10.3892/or.2014.3283
|
9480
Masatoshi Konno, Takafumi Hasegawa, Toru Baba, Emiko Miura, Naoto Sugeno, Akio Kikuchi, Fabienne C Fiesel, Tsutomu Sasaki, Masashi Aoki, Yasuto Itoyama, Atsushi Takeda
Suppression of Dynamin GTPase Decreases α-Synuclein Uptake by Neuronal and Oligodendroglial Cells: A Potent Therapeutic Target for Synucleinopathy
Mol Neurodegener
2012
7:38
PubMed ID: 22892036
DOI: 10.1186/1750-1326-7-38
|
7934
Matsuda Y, Kawamoto Y, Teduka K, Peng WX, Yamamoto T, Ishiwata T, Naito Z.
Morphological and cytoskeletal alterations of nervous system tumor cells with different culturing methods.
Int. J. Oncol.
2011
38:1253-8
PubMed ID: 21331444
DOI: 10.3892/ijo.2011.945
|
3400
Uchinokura, Shunro, Miyata, Shiro, Fukushima, Tsuyoshi, Itoh, Hiroshi, Nakano, Shinichi, Wakisaka, Shinichiro, Kataoka, Hiroaki
Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
Int J Cancer
2006
118:583-92
PubMed ID: 16106403
DOI: 10.1002/ijc.21362
|
18825
Zhang Y, Iwasaki H, Wang H, Kudo T, Kalka TB, Hennet T, Kubota T, Cheng L, Inaba N, Gotoh M, Togayachi A, Guo J, Hisatomi H, Nakajima K, Nishihara S, Nakamura M, Marth JD, Narimatsu H.
Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen
J Biol Chem
2003
278(1):573-84
PubMed ID: 12407114
DOI: 10.1074/jbc.M203094200
|
19275
Matsunaga Y, Saito N, Fujii A, Yokotani J, Takakura T, Nishimura T, Esaki H, Yamada T.
A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell
Biochem J
2002
61(Pt 3):547-56.
PubMed ID: 11802784
DOI: 10.1042/0264-6021:3610547
|
6244
Harada H, Yoshida S, Nobe Y, Ezura Y, Atake T, Koguchi T, Emi M.
Genomic structure of the human NLK (nemo-like kinase) gene and analysis of its promoter region.
Gene
2002
285(1-2):175-82
PubMed ID: 12039044
DOI: 10.1016/s0378-1119(02)00412-2
|
13875
Satoh JI, Kuroda Y.
Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors
Parkinsonism Relat Disord
2001
8(1):7-17
PubMed ID: 11472875
DOI: 10.1016/s1353-8020(00)00075-4
|
16388
S. Yoshida, K. Fukino, H. Harada, H. Nagai, I. Imoto, J. Inazawa, H. Takahashi, A. Teramoto, M. Emi
The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors
Journal of Human Genetics
2001
42:182-187
PubMed ID: 11322657
DOI: 10.1007/s100380170086
|
16913
Hamasuna R, Kataoka H, Meng JY, Itoh H, Moriyama T, Wakisaka S, Koono M.
Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells
Int J Cancer
2001
93(3):339-45
PubMed ID: 11433397
DOI: 10.1002/ijc.1349
|
5968
Satoh J, Kuroda Y.
Beta-catenin expression in human neural cell lines following exposure to cytokines and growth factors.
Neuropathology
2000
20(2):113-23
PubMed ID: 10935448
DOI: 10.1046/j.1440-1789.2000.00293.x
|
6258
Kurihara H, Zama A, Tamura M, Takeda J, Sasaki T, Takeuchi T.
Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.
Gene Ther
2000
7(8):686-93
PubMed ID: 10800092
DOI: 10.1038/sj.gt.3301129
|
6263
Brown RC, Cascio C, Papadopoulos V.
Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide.
J Neurochem
2000
74(2):847-59
PubMed ID: 10646538
DOI: 10.1046/j.1471-4159.2000.740847.x
|
18776
Satoh J, Kurohara K, Yukitake M, Kuroda Y.
Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines
J Neuropathol Exp Neurol
1998
57(2):131-9
PubMed ID: 9600205
DOI: 10.1097/00005072-199802000-00004
|
13873
Satoh J, Kurohara K, Yukitake M, Kuroda Y.
Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues
J Neurol Sci
1998
155(2):170-7
PubMed ID: 9562262
DOI: 10.1016/s0022-510x(97)00310-9
|
892
Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S.
Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells
Biochem Biophys Res Commun
1998
249(1):73-7
PubMed ID: 9705834
DOI: 10.1006/bbrc.1998.9078
|
18028
Iida M, Sunaga S, Hirota N, Kuribayashi N, Sakagami H, Takeda M, Matsumoto K.
Effect of glutathione-modulating compounds on hydrogen-peroxide-induced cytotoxicity in human glioblastoma and glioma cell lines
J Cancer Res Clin Oncol
1997
123(11-12):619-22
PubMed ID: 9620220
DOI: 10.1007/s004320050115
|
2059
Moriyama T, Kataoka H, Seguchi K, Tsubouchi H, Koono M
Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells.
Int J Cancer
1996
66:678-85
PubMed ID: 8647632
DOI: 10.1002/(SICI)1097-0215(19960529)66:5<678::AID-IJC16>3.0.CO;2-0
|
17217
Tsurushima H, Liu SQ, Tsuboi K, Yoshii Y, Nose T, Ohno T.
Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme
J Neurosurg
1996
84(2):258-63
PubMed ID: 8592229
DOI: 10.3171/jns.1996.84.2.0258
|
2058
Moriyama T, Kataoka H, Tsubouchi H, Koono M
Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro.
FEBS Lett
1995
372:78-82
PubMed ID: 7556648
DOI: 10.1016/0014-5793(95)00949-a
|